SWOG Cancer Research Network clinical trial reveals potentia

A Phase 3 trial has demonstrated that patients with advanced stage (3 or 4) classic Hodgkin lymphoma who underwent initial treatment with nivolumab, a PD-1 checkpoint inhibitor, and AVD chemotherapy (N-AVD) had a significantly lower risk of their cancer getting worse than patients treated with brentuximab vedotin, a monoclonal antibody, and AVD (BV-AVD) a year after starting treatment.

Related Keywords

Texas , United States , Toronto , Ontario , Canada , California , Glendora , Megan Craig , Sharon Castellino , Alex Herrera , Michaell Leblanc , Angela Punnett , Hongli Li , Susank Parsons , Davidc Hodgson , Kelly Davison , Carla Casulo , Karam Kelly , Sarahc Rutherford , Sharonm Castellino , Sairah Ahmed , Georgie Garabet , Bristol Myers Squibb , Brads Kahl , Andrewm Evens , Sonalim Smith , Jonathan Friedberg , Johnp Leonard , Nancyl Bartlett , Tufts Medical Center , Division Of Lymphoma , Department Of Oncology , National Clinical Trials Network , Tufts University School Of Medicine , Statistical Center , Division Of Hematology Oncology , Division Of Lymphoma At City Hope , Department Of Radiation Oncology , Fred Hutchinson Cancer Center , Department Of Pathology , Princess Margaret Cancer Centre , University Of Rochester , Mcgill University , Emory University , University Health Network , Wilmot Cancer Institute , University Of Chicago , Department Of Pediatric Oncology , Winship Cancer Institute At Emory University , Washington University School Of Medicine , National Cancer Institute , Children Oncology Group , University Of Texas Md Anderson Cancer Center , Blood Disorders Center , Cancer Therapy Evaluation Program , Roswell Park Comprehensive Cancer Center , Cancer Research Network , Lymphoma Program , Development Agreement , Rutgers Cancer Institute Of New Jersey , National Institutes Of Health , Research Network , National Institutes , Clinical Trials Network , Oncology Group , Aflac Cancer , Winship Cancer Institute , Cooperative Research , Rutgers Cancer Institute , New Jersey , Sick Children , Radiation Oncology , Tufts University School , Cancer Center , Washington University School , Pediatric Oncology , Roswell Park Comprehensive Cancer , Cancer , Research , Adolescents , Ntibody , Flood , Brentuximab Vedotin , Chemotherapy , Children , Clinical Trial , It , Healthcare , Hodgkin Lymphoma , Hospital , Lymphoma , Medicine , Monoclonal Antibody , Ncology , Pd L1 , Protein ,